Karl Deisseroth, Peter Hegemann and Georg Nagel win the 2026 Nobel Prize in Physiology or Medicine for their work on ...

Laboratories are still using dangerous and carbon-intensive liquids much more often than environmentally friendly ones, according to a 40-year survey of patents.

Glucagon-like peptide 1 (GLP-1) receptor agonists are approved for the treatment of type 2 diabetes and obesity. An emerging ...

Outcomes have improved drastically in the United States for some forms of the disease, but those for others continue to lag.

Nature’s senior biology reporter Ewen Callaway reflects on today’s prize for optogenetics — which scientists have anticipated for years.

Community Dental Services (CDS) provide essential care for vulnerable patient groups, including individuals with disabilities, complex medical ...

Transforming the Water Agenda brings together articles that highlight pressing challenges and emerging opportunities across ...

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to Karl Deisseroth, Peter Hegemann and Georg Nagel ...

An article in Nature Materials presents a polymer–lipid nanoparticle that simultaneously functions as an mRNA carrier and a T cell activator, enabling in vivo generation of functional chimeric antigen ...

Former PayPal chief executive Elon Musk develops rockets commercially at SpaceX, the space-technology firm he founded and ...

Twenty-five years after the US anthrax attacks, fears around AI are distracting people from seeing what’s needed to stay safe: a strong, regulated life-sciences sector.